- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04641039
Postoperative Scar in the Control Excess of Mobility Induced by Annulus Removal on Inserting a Lumbar Disc Prosthesis
April 18, 2026 updated by: Vicente Vanaclocha, University of Valencia
Effect of the Postoperative Prevertebral Scar on Controlling Excess After Removing the Anterior Lumbar Disc Annulus Fibrosus to Implant a Lumbar Disc Prosthesis. Biomechanical and Clinical Study
To implant a complete lumbar disc prosthesis removal of the anterior portion of the annulus fibrosus is required.
As the anterior portion of the annulus limits the movement in extension and axial rotation, we would like to know how much increase these two disc movements and also the effect on the postoperative prevertebral scar on the reduction of these abnormal movement ranges.
We also aim to see if repairing intraoperatively the anterior portion of the annulus has any advantage in the final result achieved.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
To implant a complete lumbar disc prosthesis removal of the anterior portion of the annulus fibrosus is required.
It is known that the anterior portion of the annulus limits the movement in extension and axial rotation, so removal of this section of the annulus fibrosus will increase the range of movement in extension and axial rotation.
As far as the investigators know, this increase in movement ranges has not been measured objectively in alive patients.
Also the investigators would like to know if the postoperative prevertebral scar reduces an to what extent these abnormal movement ranges.
This could help the investigators to decide when patients should be allowed to regain normal activities and specially, when the patients should be allowed to start working again.
The investigators also aim to see if repairing intraoperatively the anterior portion of the annulus has any advantage in the final result achieved, and thus represents an improvement or not in the care of these patients
Study Type
Interventional
Enrollment (Estimated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Vicente Vanaclocha, MDPhD
- Phone Number: 438500 + 34 963 13 18 00
- Email: vivava@uv.es; vvanaclo@hotmail.com
Study Contact Backup
- Name: Teresa Moratal, Secretary
- Phone Number: 437334 + 34 963 13 18 00
- Email: ceicvalencia_hgv@gva.es
Study Locations
-
-
Valencia
-
Valencia, Valencia, Spain, 46014
- Recruiting
- Hospital General Universitario de Valencia
-
Contact:
- Vicente Vanaclocha, MDPhD
- Phone Number: 438500 +34 963 13 18 00
- Email: vivava@uv.es; vvanaclo@hotmail.com
-
Contact:
- Teresa Moratal
- Phone Number: 437334 +34 963 13 18 00
- Email: ceicvalencia_hgv@gva.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Minimum age of 18 years and maximum of 50 years, given that above that age there is usually degenerative pathology of the lumbar joint facets, which can confuse the symptoms and make it difficult to interpret the results.
- Pathology compatible with chronic low back pain accompanied or not by radiculopathy originating in one or a maximum of two degenerated intervertebral discs and without signs of degeneration / osteoarthritis of the lumbar joint facets.
- The type of lumbar pain must be discogenic, that is, worsen in flexion and not in extension, and in loading, as well as having a truncal distribution with possible anterior radiation towards the English or genital region.
- Radiological confirmation by lumbar MRI study of lumbar discopathy of one or a maximum of two lumbar levels.
- Absence in simple radiology studies of signs of vertebral instability or listhesis of the levels to be treated.
- Absence of response for 6 weeks to conservative, non-surgical treatment, or presence of progressive symptoms. The treatment would also be carried out despite the absence of this study and the existence of the study does not condition in any way the treatment of the patients
- Not having undergone any prior treatment of the type of microdiscectomy, laminectomy or lumbar arthrodesis, although these have been carried out at different levels than those involved on this occasion
- Ability of the patient to comply with the proposed monitoring program
- Patient's ability to follow the postoperative care program
- Granting of informed consent
Exclusion Criteria:
- Signs of arthropathy of the lumbar joint facets, osteoporosis, previous interventions on the lumbar spine
- Deformity or instability of the lumbar spine
- Lumbar canal stenosis
- Previous intervention on lumbar spine
- Previous lumbar spinal fracture
- Mobile spondylolisthesis> 2 mm in translation and / or more than 11 ° angular difference with respect to the adjacent level on neutral vertical or flexion-extension radiographs
- Severe osteoporosis
- Spinal metastasis
- Metabolic bone disease that could interfere with the implant or the surgical procedure
- Rheumatoid arthritis, lupus, or other autoimmune disease that affects the musculoskeletal system
- Other conditions or anatomical alterations that make the treatment of the anterior approach to the lumbar spine unfeasible
- Known allergy to stainless steel, titanium or their alloys
- Fixed or permanent neurological deficit
- Active systemic infection at any time or ongoing preventive treatment for it, infection in the surgical site, HIV or hepatitis C
- Abusive drug or alcohol use
- Uncontrolled seizure disorder
- Psychiatric illness that could interfere with your participation in the study
- Participation in a current research study or in the 3 months prior to surgery
- History of malignancy or current malignancy (except non-melanoma skin cancer), unless the patient has been treated for curative purposes and no clinical signs or symptoms have been observed for at least 5 years
- Obesity (Body Mass Index or BMI> 35)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Anterior annulus removal
In these patients the anterior portion of the annulus fibrosus will be removed when inserting a complete lumbar disc prosthesis
|
Owestry scale, SF12, Facet joint arthritis measured with Pathria scale, discal degeneration measured with Modic and Phirrmann scales
|
|
Active Comparator: Anterior annulus replacement
In these group of patients the anterior portion of the annulus fibrosus will be opened up in to flaps hinged lateraly and replaced once the complete lumbar disc prosthesis is inserted
|
Owestry scale, SF12, Facet joint arthritis measured with Pathria scale, discal degeneration measured with Modic and Phirrmann scales
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of spinal segment movement after lumbar disc prosthesis insertion in L4-L5 lumbar disc
Time Frame: One year
|
The investigators will analyze preoperatively and postoperatively at 3, 6 and 12 months the range of movement of the L4-L5 lumbar disc after insertion of a complete lumbar disc prosthesis
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Auerbach JD, Jones KJ, Milby AH, Anakwenze OA, Balderston RA. Segmental contribution toward total lumbar range of motion in disc replacement and fusions: a comparison of operative and adjacent levels. Spine (Phila Pa 1976). 2009 Nov 1;34(23):2510-7. doi: 10.1097/BRS.0b013e3181af2622.
- Huang YJ, Zhao SJ, Zhang Q, Nong LM, Xu NW. Comparison of lumbar pedicular dynamic stabilisation systems versus fusion for the treatment of lumbar degenerative disc disease: A meta-analysis. Acta Orthop Belg. 2017 Mar;83(1):180-193.
- Frelinghuysen P, Huang RC, Girardi FP, Cammisa FP Jr. Lumbar total disc replacement part I: rationale, biomechanics, and implant types. Orthop Clin North Am. 2005 Jul;36(3):293-9. doi: 10.1016/j.ocl.2005.02.014.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Estimated)
December 28, 2029
Study Completion (Estimated)
December 28, 2029
Study Registration Dates
First Submitted
November 12, 2020
First Submitted That Met QC Criteria
November 19, 2020
First Posted (Actual)
November 23, 2020
Study Record Updates
Last Update Posted (Actual)
April 22, 2026
Last Update Submitted That Met QC Criteria
April 18, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 101/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Disease
-
Locate Bio Pty LtdRecruitingDegenerative Disc Disease | Lumbar Disc Disease | Spine Disease | Lumbar Spine DegenerationAustralia, United States
-
Providence Medical Technology, Inc.RecruitingRadiculopathy Lumbar | Degenerative Lumbar Disc DiseaseUnited States
-
Cantonal Hospital of St. GallenProf. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St.... and other collaboratorsCompletedLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine DegenerationSwitzerland
-
[Redacted]WithheldLumbar Disc Herniation | Degenerative Disc Disease | Lumbar Spinal Stenosis | Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Radiculopathy | Lumbar Disc Disease | Spine Disease | Lumbar Spine Degeneration | Degenerative SpondylolisthesisAustralia
-
Globus Medical IncRecruiting
-
Spinal ElementsCompletedLumbar Disc DiseaseUnited States
-
Ramsay Générale de SantéCompletedSurgical Procedure, Unspecified | Lumbar Disc DiseaseFrance
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Rush University Medical CenterCompletedLumbar Degenerative Disc Disease | Lumbar Degenerative Disease | Degenerative SpineUnited States
Clinical Trials on Anterior lumbar disc annulus removal versus replacement
-
Svante BergYara AsterfjordWithdrawnDisk Degeneration | Disc Disease Degenerative | Disc Disease LumbarSweden
-
Technische Universität DresdenUnknown
-
Technische Universität DresdenUnknown
-
NuVasiveCompletedDegenerative Disc DiseaseUnited States
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsCompletedChronic Low Back PainNorway
-
Barrett, William, M.D.Johnson & JohnsonCompletedOsteoarthritis of the HipUnited States
-
Peking University People's HospitalUnknownCervical Spondylosis
-
Hadassah Medical OrganizationUnknownMotor Impairments | Orthopaedic Injuries | Neurological ConditionsIsrael